27 sierpnia, 2020
Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
Purpose of review: Immune checkpoint inhibitors targeting the programmed cell death-1 (PD-1) pathway are a class of anti-cancer immunotherapy agents changing treatment paradigms of many cancers that occur at higher rates in people living with HIV (PLWH) than in the general population. However, PLWH have been excluded from most of the initial clinical trials with these agents.
Recent findings: Two recent prospective studies of anti-PD-1 agents, along with observational studies and a meta-analysis, have demonstrated acceptable safety in PLWH. Preliminary evidence indicates activity in a range of tumors and across CD4+ T cell counts.
Safety and preliminary activity data suggest monoclonal antibodies targeting PD-1 or its ligand, PD-L1, are generally appropriate for PLWH and cancers for which there are FDA-approved indications. Ongoing and future trials of anti-PD-1 and anti-PD-L1 therapy alone or in combination for HIV-associated cancers may further improve outcomes for this underserved population.
KIR2DL4 siRNA (Human) |
|||
MBS8221428-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
PE anti-human CD158d (KIR2DL4) |
|||
E16FHP158d-025 | EnoGene | 25 tests | EUR 541.67 |
Description: Available in various conjugation types. |
PE anti-human CD158d (KIR2DL4) |
|||
E16FHP158d-100 | EnoGene | 100 tests | EUR 1278.33 |
Description: Available in various conjugation types. |
Human KIR2DL4 ELISA KIT |
|||
ELI-21303h | Lifescience Market | 96 Tests | EUR 988.8 |
APC anti-human CD158d (KIR2DL4) |
|||
E16FHA158d-025 | EnoGene | 25 tests | EUR 563.33 |
Description: Available in various conjugation types. |
APC anti-human CD158d (KIR2DL4) |
|||
E16FHA158d-100 | EnoGene | 100 tests | EUR 1321.67 |
Description: Available in various conjugation types. |
Human KIR2DL4 shRNA Plasmid |
|||
20-abx952576 | Abbexa |
|
|
|
Human KIR2DL4 Protein Lysate |
|||
MBS8414061-002mg | MyBiosource | 0.02mg | EUR 365 |
Human KIR2DL4 Protein Lysate |
|||
MBS8414061-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
Mouse Monoclonal anti-human KIR2DL4 |
|||
hAP-0441 | Angio Proteomie | 100ug | EUR 250 |
Recombinant Human KIR2DL4 Protein |
|||
MBS8249336-001mg | MyBiosource | 0.01mg | EUR 210 |
Recombinant Human KIR2DL4 Protein |
|||
MBS8249336-005mg | MyBiosource | 0.05mg | EUR 420 |
Recombinant Human KIR2DL4 Protein |
|||
MBS8249336-05mg | MyBiosource | 0.5mg | EUR 2420 |
Recombinant Human KIR2DL4 Protein |
|||
MBS8249336-5x05mg | MyBiosource | 5x0.5mg | EUR 10810 |
Human KIR2DL4 Protein, Fc Tag |
|||
E40KMPH4155 | EnoGene | 20ug | EUR 495 |
Human KIR2DL4 Protein, Fc Tag |
|||
E40KMPH4156 | EnoGene | 20ug | EUR 495 |
KIR2DL4 Protein, Human, Recombinant |
|||
E45H52011M0-100 | EnoGene | 100 ug | EUR 1046.77 |
KIR2DL4 Protein, Human, Recombinant |
|||
MBS8121253-01mg | MyBiosource | 0.1mg | EUR 395 |
KIR2DL4 Protein, Human, Recombinant |
|||
MBS8121253-5x01mg | MyBiosource | 5x0.1mg | EUR 1635 |
KIR2DL4 Recombinant Protein (Human) |
|||
RP017041 | ABM | 100 ug | Ask for price |
NE Purified anti-human CD158d (KIR2DL4) |
|||
E16FHY158d-050U | EnoGene | 50 μg | EUR 845 |
Description: Available in various conjugation types. |
Human KIR2DL4 knockout cell line |
|||
ABC-KH7929 | AcceGen | 1 vial | Ask for price |
Description: Human KIR2DL4 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
KIR2DL4 ORF Vector (Human) (pORF) |
|||
ORF005681 | ABM | 1.0 ug DNA | EUR 114 |
Human KIR2DL4 knockdown cell line |
|||
ABC-KD7929 | AcceGen | 1 vial | Ask for price |
Description: Human KIR2DL4 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human KIR2DL4 Protein Lysate 20ug |
|||
IHUKIR2DL4PLLY20UG | Innovative research | each | EUR 213 |
|
|||
Description: Human KIR2DL4 Protein Lysate 20ug |
KIR2DL4 |
|||
CSB-CL857457HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
KIR2DL4 |
|||
MBS8535639-01mL | MyBiosource | 0.1mL | EUR 325 |
KIR2DL4 |
|||
MBS8535639-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
KIR2DL4 |
|||
MBS8535639-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
KIR2DL4 |
|||
MBS8535639-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
KIR2DL4 |
|||
MBS8535639-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
KIR2DL4 |
|||
MBS8561736-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
KIR2DL4 |
|||
MBS8561736-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
KIR2DL4 |
|||
MBS8561736-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
KIR2DL4 |
|||
MBS8561736-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
KIR2DL4 |
|||
MBS8561736-02mL | MyBiosource | 0.2mL | EUR 345 |
KIR2DL4 |
|||
pro-2460 | ProSpec Tany | 1µg | EUR 60 |
Description: Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Long Cytoplasmic Tail 4 |
KIR2DL4 (NM_002255) Human Over-expression Lysate |
|||
LS003805 | BosterBio | 100ug | EUR 628 |
|
|||
Description: Transient overexpression lysate of killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), transcript variant 1 |
KIR2DL4 (NM_001080770) Human Over-expression Lysate |
|||
E45H05044-2 | EnoGene | each | EUR 395 |
KIR2DL4 (NM_002255) Human Over-expression Lysate |
|||
E45H06116-2 | EnoGene | each | EUR 395 |
Recombinant Human KIR2DL4 / CD158D Protein |
|||
MBS2545425-01mg | MyBiosource | 0.1mg | EUR 685 |
Recombinant Human KIR2DL4 / CD158D Protein |
|||
MBS2545425-5x01mg | MyBiosource | 5x0.1mg | EUR 3080 |
Human KIR2DL4/CD158d Recombinant Protein |
|||
PROTQ99706 | BosterBio | Regular: 5ug | EUR 350 |
Description: Human KIR2DL4/CD158d Recombinant Protein expressed in Baculovirus with hIgG-His-tag. Sequence domain: 24-242aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method). |
Recombinant Human KIR2DL4/CD158D Protein |
|||
PKSH030752-100ug | Elabscience Biotech | 100ug | EUR 732 |
|
|||
Description: Human |
KIR2DL4 antibody |
|||
70R-2365 | Fitzgerald | 50 ug | EUR 467 |
|
|||
Description: Rabbit polyclonal KIR2DL4 antibody raised against the middle region of KIR2DL4 |
KIR2DL4 Antibody |
|||
DF13591 | Affbiotech | 100ul | EUR 420 |
KIR2DL4 Antibody |
|||
DF13591-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
|||
Description: WB,IHC,IF/ICC,ELISA(peptide) |
KIR2DL4 Antibody |
|||
DF13591-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
|||
Description: WB,IHC,IF/ICC,ELISA(peptide) |
KIR2DL4 Antibody |
|||
GWB-MP022D | GenWay Biotech | 50ug | Ask for price |
KIR2DL4 Antibody |
|||
E912836 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
KIR2DL4 Antibody |
|||
E309374 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
KIR2DL4 Antibody |
|||
MBS9612350-01mL | MyBiosource | 0.1mL | EUR 260 |
KIR2DL4 Antibody |
|||
MBS9612350-02mL | MyBiosource | 0.2mL | EUR 305 |
KIR2DL4 Antibody |
|||
MBS9612350-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
Human KIR2DL4 / CD158d Protein, Fc Tag |
|||
KI4-H5255 | ACROBIOSYSTEMS | 100ug | EUR 2801.3 |
|
|||
Description: Human KIR2DL4, Fc Tag (KI4-H5255) is expressed from human 293 cells (HEK293). It contains AA His 24 - His 242 (Accession # Q99706-1). |
Recombinant Human KIR2DL4 Protein, His Tag |
|||
E40KMH1307 | EnoGene | 20ug | EUR 495 |
Recombinant Human KIR2DL4 protein (C-6His) |
|||
CD01424-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 188 |
|
|||
Description: Recombinant Human Killer Cell immunoglobulin-like Receptor 2DL4 is produced by our Mammalian expression system and the target gene encoding Trp22-His242 is expressed with a 6His tag at the C-terminus. |
Recombinant Human KIR2DL4 protein (C-6His) |
|||
CD01424-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | EUR 517 |
|
|||
Description: Recombinant Human Killer Cell immunoglobulin-like Receptor 2DL4 is produced by our Mammalian expression system and the target gene encoding Trp22-His242 is expressed with a 6His tag at the C-terminus. |
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
AP75042 | SAB | 1mg | EUR 3209 |
|
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
C310-10ug | Novoprotein | 10ug | EUR 157.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
C310-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
C310-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
C310-50ug | Novoprotein | 50ug | EUR 327.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
KIR2DL4 Protein, Human, Recombinant (hFc Tag) |
|||
E45H52119M4-100 | EnoGene | 100 ug | EUR 1046.77 |
KIR2DL4 Protein, Human, Recombinant (hFc Tag) |
|||
MBS8121252-01mg | MyBiosource | 0.1mg | EUR 395 |
KIR2DL4 Protein, Human, Recombinant (hFc Tag) |
|||
MBS8121252-5x01mg | MyBiosource | 5x0.1mg | EUR 1635 |
KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
abx210854-100l | Abbexa | 100 µl | EUR 350 |
KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
20-abx210854 | Abbexa |
|
|
|
KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
abx210854-50l | Abbexa | 50 µl | EUR 250 |
KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
abx339417-100l | Abbexa | 100 µl | EUR 350 |
KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
20-abx339417 | Abbexa |
|
|
|
KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
abx339417-50l | Abbexa | 50 µl | EUR 250 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
MBS7125228-005mL | MyBiosource | 0.05mL | EUR 190 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
MBS7125228-01mL | MyBiosource | 0.1mL | EUR 270 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
MBS7125228-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
MBS7125229-005mL | MyBiosource | 0.05mL | EUR 190 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
MBS7125229-01mL | MyBiosource | 0.1mL | EUR 270 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
MBS7125229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
1-CSB-PA205578 | Cusabio |
|
|
|
|||
Description: A polyclonal antibody against KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4. Recognizes KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
1-CSB-PA246816 | Cusabio |
|
|
|
|||
Description: A polyclonal antibody against KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4. Recognizes KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:50-1:100 |
CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma
Background: Uterine leiomyosarcoma is a rare and aggressive gynecologic malignancy originating in the myometrium of the uterine corpus that tends to recur even after complete surgical excision. Current therapeutic agents have only modest effects on uterine leiomyosarcoma.
Although antibodies and antibody-drug conjugates (ADCs) have been recognized as useful targeted therapies for other cancers, no study has yet evaluated the effects of this approach on uterine leiomyosarcoma.
Objective: To examine the activity of tumoral cluster of differentiation 70 (CD70) in uterine leiomyosarcoma and assess the antitumor activity of CD70-ADC treatment in uterine leiomyosarcoma.
Study design: Target membrane proteins were screened by profiling and comparing membrane protein expression in three uterine leiomyosarcoma cell lines (SK-UT-1, SK-LMS-1, and SKN) and normal uterine myometrium cells using the isobaric tags for relative and absolute quantitation labeling method.
Western blotting, fluorescence-activated cell sorting analyses, and immunohistochemistry were used to examine CD70 expression in the membrane proteins in uterine leiomyosarcoma cell lines and clinical samples. We developed an ADC with a monoclonal antibody of the target membrane protein linked to monomethyl auristatin F (MMAF) and investigated its antitumor effects against uterine leiomyosarcoma (in-vitro, in-vivo, and in patient-derived xenograft [PDX] models).
Results: CD70 was identified as a specific antigen highly expressed in uterine leiomyosarcoma cell lines. Of the three uterine leiomyosarcoma cell lines, CD70 expression was confirmed in SK-LMS-1 cells by western blotting and fluorescence-activated cell sorting analysis. CD70 overexpression was observed in 19 of 21 (90.5%) tumor specimens from women with uterine leiomyosarcoma.
To generate CD70-ADC, anti-CD70 monoclonal antibody was conjugated with a novel derivative of MMAF. CD70-ADC showed significant antitumor effects on SK-LMS-1 cells (IC50 0.120 nM) and no antitumor effects on CD70-negative uterine leiomyosarcoma cells.
CD70-ADC significantly inhibited tumor growth in the SK-LMS-1 xenograft mouse model (tumor volume: 129.8 versus 285.5 mm3, 54.5% relative reduction, P<0.001) and PDX mouse model (tumor volume: 128.1 versus 837.7 mm3, 84.7% relative reduction, P<0.001).
Conclusion: Uterine leiomyosarcoma tumors highly express CD70 and targeted therapy with CD70-ADC may have a potential therapeutic implication in the treatment of uterine leiomyosarcoma.
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study
Introduction: This pilot study evaluated the imaging performance of pretargeted immunological positron emission tomography (immuno-PET) using an anti-carcinoembryonic antigen (CEA) recombinant bispecific monoclonal antibody (BsMAb), TF2 and the [68Ga]Ga-labelled HSG peptide, IMP288, in patients with metastatic colorectal carcinoma (CRC).
Patients and methods: Patients requiring diagnostic workup of CRC metastases or in case of elevated CEA for surveillance were prospectively studied. They had to present with elevated CEA serum titre or positive CEA tumour staining by immunohistochemistry of a previous biopsy or surgical specimen.
All patients underwent endoscopic ultrasound (EUS), chest-abdominal-pelvic computed tomography (CT), abdominal magnetic resonance imaging (MRI) and positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET).
For immuno-PET, patients received intravenously 120 nmol of TF2 followed 30 h later by 150 MBq of [68Ga]Ga-labelled IMP288, both I.V. The gold standard was histology and imaging after 6-month follow-up.
Results: Eleven patients were included. No adverse effects were reported after BsMAb and peptide injections. In a per-patient analysis, immuno-PET was positive in 9/11 patients. On a per-lesion analysis, 12 of 14 lesions were positive with immuno-PET.
Median SUVmax, MTV and TLG were 7.65 [3.98-13.94, SD 3.37], 8.63 cm3 [1.98-46.64; SD 14.83] and 37.90 cm3 [8.07-127.5; SD 43.47] respectively for immuno-PET lesions. Based on a per-lesion analysis, the sensitivity, specificity, positive-predictive value and negative-predictive value were, respectively, 82%, 25%, 82% and 25% for the combination of EUS/CT/MRI; 76%, 67%, 87% and 33% for FDG-PET; and 88%, 100%, 100% and 67% for immuno-PET. Immuno-PET had an impact on management in 2 patients.
Conclusion: This pilot study showed that pretargeted immuno-PET using anti-CEA/anti-IMP288 BsMAb and a [68Ga]Ga-labelled hapten was safe and feasible, with promising diagnostic performance.
Trial registration: ClinicalTrials.gov NCT02587247 Registered 27 October 2015.
Anti-Human Resistin |
|||
GWB-BIG87E | GenWay Biotech | 500ug | Ask for price |
Anti-Human Resistin |
|||
MBS550711-01mg | MyBiosource | 0.1mg | EUR 260 |
Anti-Human Resistin |
|||
MBS550711-02mg | MyBiosource | 0.2mg | EUR 335 |
Human Resistin |
|||
90233-A | BPS Bioscience | 5 µg | EUR 130 |
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli. |
Human Resistin |
|||
90233-B | BPS Bioscience | 25 µg | EUR 205 |
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli. |
Human resistin |
|||
MBS400069-001mg | MyBiosource | 0.01mg | EUR 220 |
Human resistin |
|||
MBS400069-005mg | MyBiosource | 0.05mg | EUR 545 |
Human resistin |
|||
MBS400069-01mg | MyBiosource | 0.1mg | EUR 770 |
Human resistin |
|||
MBS400069-1mg | MyBiosource | 1mg | EUR 3830 |
Human Resistin |
|||
MBS692069-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human Resistin |
|||
MBS692069-0025mg | MyBiosource | 0.025mg | EUR 450 |
Human Resistin |
|||
MBS692069-5x0025mg | MyBiosource | 5x0.025mg | EUR 1725 |
Human Resistin Antibody |
|||
32138-05111 | AssayPro | 150 ug | EUR 215 |
Human Resistin Antibody |
|||
GWB-F7AAE4 | GenWay Biotech | 0.1 mg | Ask for price |
Resistin (43-65) (Human) - Antibody |
|||
H-028-39 | PHOENIX PEPTIDE | 50 μl | EUR 604.8 |
Resistin (51-108) (Human) - Antibody |
|||
H-028-40 | PHOENIX PEPTIDE | 50 μl | EUR 604.8 |
Resistin (43-65) (Human) |
|||
028-39 | PHOENIX PEPTIDE | 100 μg | EUR 255.96 |
Resistin (51-108) (Human) |
|||
028-40 | PHOENIX PEPTIDE | 20 μg | EUR 282.96 |
Resistin (23-42) (Human) |
|||
028-41 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Resistin (25-42) (Human) |
|||
028-42 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Mouse Anti-Human Resistin |
|||
MBS690775-05mg | MyBiosource | 0.5mg | EUR 525 |
Mouse Anti-Human Resistin |
|||
MBS690775-5x05mg | MyBiosource | 5x0.5mg | EUR 2080 |
Human Resistin (RETN) |
|||
1-CSB-EP019573HU | Cusabio |
|
|
|
|||
Description: Recombinant Human Resistin(RETN) expressed in E.coli |
Human resistin antagonist |
|||
MBS400115-001mg | MyBiosource | 0.01mg | EUR 220 |
Human resistin antagonist |
|||
MBS400115-005mg | MyBiosource | 0.05mg | EUR 545 |
Human resistin antagonist |
|||
MBS400115-01mg | MyBiosource | 0.1mg | EUR 770 |
Human resistin antagonist |
|||
MBS400115-1mg | MyBiosource | 1mg | EUR 3830 |
Anti-Human Resistin Antibody |
|||
101-M170 | ReliaTech | 500 µg | EUR 246.75 |
Description: Resistin belongs to a family of tissue-specific cytokines termed FIZZ (found in inflammatory zones) and RELM. The three known members of this family; Resistin, RELM-α and RELM-β share a highly conserved C-terminal domain, characterized by 10 cysteine residues with a unique spacing motif of C-X11-C-X8-C-X-C-X3-C-X10-C-X-C-X-C-X9-C-C. Resistin is an adipose-derived cytokine (adipokine) whose physiological function and molecular targets are largely unknown. Studies have shown that Resistin suppresses insulin's ability to stimulate glucose uptake, and postulated that Resistin might be an important link between obesity and Type 2 diabetes. Other studies have indicated that Resistin expression is severely suppressed in obesity and that it may act as a feedback regulator of Adipogenesis. Recombinant human Resistin is a 19.5 kDa disulfide-linked homodimeric protein composed of two identical 92 amino acid chains linked by a single disulfide bond. |
Anti-Human Resistin Antibody |
|||
101-M618 | ReliaTech | 100 µg | EUR 399 |
Description: Resistin belongs to a family of tissue-specific cytokines termed FIZZ (found in inflammatory zones) and RELM. The three known members of this family; Resistin, RELM-α and RELM-β share a highly conserved C-terminal domain, characterized by 10 cysteine residues with a unique spacing motif of C-X11-C-X8-C-X-C-X3-C-X10-C-X-C-X-C-X9-C-C. Resistin is an adipose-derived cytokine (adipokine) whose physiological function and molecular targets are largely unknown. Studies have shown that Resistin suppresses insulin's ability to stimulate glucose uptake, and postulated that Resistin might be an important link between obesity and Type 2 diabetes. Other studies have indicated that Resistin expression is severely suppressed in obesity and that it may act as a feedback regulator of Adipogenesis. |
Anti-Human Resistin Antibody |
|||
102-P92G | ReliaTech | 100 µg | EUR 245.7 |
Description: Resistin belongs to a family of tissue-specific cytokines termed FIZZ (found in inflammatory zones) and RELM. The three known members of this family; Resistin, RELM-α and RELM-β share a highly conserved C-terminal domain, characterized by 10 cysteine residues with a unique spacing motif of C-X11-C-X8-C-X-C-X3-C-X10-C-X-C-X-C-X9-C-C. Resistin is an adipose-derived cytokine (adipokine) whose physiological function and molecular targets are largely unknown. Studies have shown that Resistin suppresses insulin's ability to stimulate glucose uptake, and postulated that Resistin might be an important link between obesity and Type 2 diabetes. Other studies have indicated that Resistin expression is severely suppressed in obesity and that it may act as a feedback regulator of Adipogenesis. |
Biotinylated Anti-Human Resistin |
|||
GWB-BIG87D | GenWay Biotech | 1 kit | Ask for price |
Recombinant Human Resistin |
|||
7-01519 | CHI Scientific | 5µg | Ask for price |
Recombinant Human Resistin |
|||
7-01520 | CHI Scientific | 25µg | Ask for price |
Recombinant Human Resistin |
|||
7-01521 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Resistin |
|||
cyt-456-1mg | ProSpec Tany | 1mg | EUR 4680 |
Recombinant Human Resistin |
|||
cyt-456-25g | ProSpec Tany | 25µg | EUR 145 |
Recombinant Human Resistin |
|||
cyt-456-5g | ProSpec Tany | 5µg | EUR 60 |
RECOMBINANT HUMAN RESISTIN |
|||
GWB-F4A137 | GenWay Biotech | 0.02 mg | Ask for price |
Recombinant Human Resistin |
|||
MBS1410331-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human Resistin |
|||
MBS1410331-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human Resistin |
|||
MBS1410331-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human Resistin |
|||
MBS1410331-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
Recombinant Human Resistin |
|||
MBS142332-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human Resistin |
|||
MBS142332-0025mg | MyBiosource | 0.025mg | EUR 310 |
Recombinant Human Resistin |
|||
MBS142332-1mg | MyBiosource | 1mg | EUR 4895 |
Recombinant Human Resistin |
|||
MBS142332-5x1mg | MyBiosource | 5x1mg | EUR 21695 |
RECOMBINANT HUMAN RESISTIN |
|||
MBS232425-0025mg | MyBiosource | 0.025mg | EUR 510 |
RECOMBINANT HUMAN RESISTIN |
|||
MBS232425-5x0025mg | MyBiosource | 5x0.025mg | EUR 2130 |
Human Resistin Recombinant |
|||
MBS553192-0005mg | MyBiosource | 0.005mg | EUR 165 |
Human Resistin Recombinant |
|||
MBS553192-0025mg | MyBiosource | 0.025mg | EUR 245 |
Recombinant Human Resistin |
|||
MBS7611410-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human Resistin |
|||
MBS7611410-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human Resistin |
|||
MBS7611410-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human Resistin |
|||
MBS7611410-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Human Resistin |
|||
MBS9420612-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant Human Resistin |
|||
MBS9420612-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Human Resistin |
|||
MBS9420612-1mg | MyBiosource | 1mg | EUR 1785 |
Recombinant Human Resistin |
|||
MBS9420612-5x1mg | MyBiosource | 5x1mg | EUR 7885 |
Human Resistin CLIA Kit |
|||
MBS8425884-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Resistin, human recombinant |
|||
4559-100 | Biovision | each | EUR 874.8 |
Resistin, human recombinant |
|||
4559-1000 | Biovision | each | EUR 6127.2 |
Resistin, human recombinant |
|||
4559-25 | Biovision | each | EUR 307.2 |
Resistin, recombinant (Human) |
|||
028-36 | PHOENIX PEPTIDE | 20 μg | EUR 423.36 |
Resistin (Recombinant) Human |
|||
GWB-8EE40A | GenWay Biotech | 0.025 mg | Ask for price |
Resistin Human Recombinant |
|||
rAP-0727 | Angio Proteomie | Inquiry | Ask for price |
human Resistin ELISA KIT |
|||
201-12-0339 | Shanghai Sunred Biological Technology | 96 tests | EUR 528 |
|
|||
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
human Resistin ELISA Kit |
|||
MBS700822-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 4795 |
human Resistin ELISA Kit |
|||
MBS700822-24StripWellsLIMIT1 | MyBiosource | 24-Strip-Wells(LIMIT1) | EUR 275 |
human Resistin ELISA Kit |
|||
MBS700822-48StripWells | MyBiosource | 48-Strip-Wells | EUR 415 |
human Resistin ELISA Kit |
|||
MBS700822-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2515 |
human Resistin ELISA Kit |
|||
MBS700822-96StripWells | MyBiosource | 96-Strip-Wells | EUR 580 |
Human Resistin ELISA Kit |
|||
MBS720386-48StripWellsCompetitive | MyBiosource | 48-Strip-Wells-(Competitive) | EUR 485 |
Human Resistin ELISA Kit |
|||
MBS720386-48StripWellsSandwich | MyBiosource | 48-Strip-Wells-(Sandwich) | EUR 485 |
Human Resistin ELISA Kit |
|||
MBS720386-5x96StripWellsCompetitive | MyBiosource | 5x96-Strip-Wells-(Competitive) | EUR 3020 |
Human Resistin ELISA Kit |
|||
MBS720386-96StripWellsCompetitive | MyBiosource | 96-Strip-Wells-(Competitive) | EUR 690 |
Human Resistin ELISA Kit |
|||
MBS720386-96StripWellsSandwich | MyBiosource | 96-Strip-Wells-(Sandwich) | EUR 690 |
Human Resistin ELISA Kit |
|||
E16HE0035 | EnoGene | 96T | EUR 833.33 |
Human Resistin ELISA KIT |
|||
E16HE0035-048 | EnoGene | 48 wells | EUR 295 |
Human Resistin ELISA KIT |
|||
E16HE0035-096 | EnoGene | 96 wells | EUR 395 |
Human Resistin ELISA kit |
|||
E01R0351-192T | BlueGene | 192 tests | EUR 1524 |
|
|||
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Resistin ELISA kit |
|||
E01R0351-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
|||
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Resistin ELISA kit |
|||
E01R0351-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
|||
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |